Shanghai Huilun Pharmaceutical Co., Ltd.
Clinical trials sponsored by Shanghai Huilun Pharmaceutical Co., Ltd., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New oral painkiller aims to ease recovery after abdominal surgery Results expected Oct 2026 (estimated)
- New oral painkiller aims to ease recovery after orthopedic surgery Results expected Oct 2026 (estimated)
-
New oral painkiller aims to ease recovery after abdominal surgery
Symptom relief Recruiting nowThis clinical trial tests an experimental painkiller called HL-1186 for people recovering from abdominal surgery. The study compares HL-1186 to a placebo and to a standard painkiller (oxycodone-acetaminophen) to see how well it controls pain and whether it is safe. Participants a…
Phase 2/3 • Sponsor: Shanghai Huilun Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Jul 18, 2026 00:00 UTC
-
New oral painkiller aims to ease recovery after orthopedic surgery
Symptom relief Recruiting nowThis clinical trial tests an experimental painkiller called HL-1186 for people recovering from orthopedic surgery (bone or joint surgery). The study compares HL-1186 against a placebo (dummy pill) and a standard painkiller (oxycodone-acetaminophen) to see how well it controls pai…
Phase 2/3 • Sponsor: Shanghai Huilun Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Jul 15, 2026 00:00 UTC